Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support

Clinical trial NCT07456670 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07456670
Sponsor: Queen's University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Preterm Birth Caffeine Neonatal Outcomes

Start date: 2026-04-01
Primary completion: 2028-03-31
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.